Documentos de Valenzuela-Silva C.M. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Objetivos de Desarrollo Sostenible: "ODS 9: Industria, innovación e infraestructura"

Subtipo de publicación

Publisher

Biopharmaceutics and Drug Disposition(1)

European Journal of Pharmaceutical Sciences(1)

International Immunopharmacology(1)

Journal of Neuroimmune Pharmacology(1)

Área temáticas

Enfermedades(3)

Farmacología y terapéutica(2)

Fisiología humana(2)

Microorganismos, hongos y algas(1)

Sistemas fisiológicos específicos de los animales(1)

Área de conocimiento

Farmacología(2)

Inmunología(1)

Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar(4)

ODS 10: Reducción de las desigualdades(3)

ODS 12: Producción y consumo responsables(1)

Año de Publicación

Origen

Palabras Claves

Multiple Sclerosis(2)

Allometric scaling(1)

C-Phycocyanin(1)

Central nervous system(1)

Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice

Abstract: Multiple Sclerosis (MS) therapies approved so far are unable to effectively reverse the chronic phas

Palabras claves:

C-Phycocyanin, EAE, IFN-beta, Multiple Sclerosis, Neuroregeneration, Remyelination

Alexey Llópiz-Arzuaga, Bergami A., Fernández-Massó J.R., Furlan R., Herrera-Rolo T., Lagumersindez-Denis N., Marín-Prida J., Muzio L., Nazabal-Galvez M., Pentón-Arias E., Pentón-Rol G., Polentarutti N., Raíces-Cruz I., Teixeira M.M., Valenzuela-Silva C.M., Veliz-Rodriguez T.

C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells

Abstract: For decades Experimental Autoimmune Encephalitis (EAE) has remained as an unsurpassed multiple scler

Palabras claves:

Central nervous system, Demyelination, Multiple Sclerosis, Neurodegenerative disorder, Regulatory T cells

Acosta-Medina E.F., Alexey Llópiz-Arzuaga, Alonso-Ramírez R., Cervantes-Llanos M., Falcón-Cama V., Guillén-Nieto G.E., Lagumersindez-Denis N., López-Saura P.A., Marín-Prida J., Martínez-Sánchez G., Pentón-Arias E., Pentón-Rol G., Rodríguez-Jiménez E., Valenzuela-Silva C.M.

Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody

Abstract: The multiple-dose strategy with the monoclonal ior EGF/r3 antibody, in xenograft bearing nude mice,

Palabras claves:

Allometric scaling, Dosage regimen, Integrated pharmacokinetic-pharmacodynamic, Monoclonal antibody ior EGF/r3, Survival time, Tumor growth delay

Alonso K., Alvarez D., Beausoleil I., Bécquer M.d.l.A., Castillo R., Duconge J., Fernández-Sánchez E.M., Matheu J., Tania Crombet, Valenzuela-Silva C.M., Vecino G.

Topical disposition of two strengths of a <sup>125</sup>I-rhEGF jelly in rat skin wounds

Abstract: Growth factors have proved to be an effective therapeutic strategy. However, some controversies have

Palabras claves:

125 I-rhEGF, Jelly, Non-linearity, Strength, Topical disposition

Aguilera A., Alfonso-Ortíz S., Alvarez D., Bécquer M.d.l.A., Duconge J., Estrada L., Eugenio Hardy, Fernández-Sánchez E.M., García-Pulpeiro O., Prats P.A., Rojas I., Valenzuela-Silva C.M.